Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Jan 02, 2019
The promise and dangers of editing the genome of a human embryo are being discussed by scientists around the world. They are contemplating whether it should be allowed or not— and if so, under what circumstances? The meetings have been prompted by the powerful technology known as CRISPR/Cas9. This could be use...
Read More...
Dec 07, 2016
Fabián Díaz achieved a milestone last year when he derived the first human embryonic stem-cell line from cells of Mexican origin. Biologists across Mexico now use the stem cells, which Díaz — a researcher at the National Institute of Perinatology in Mexico City — created using embryos discarded by a fertility clinic...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper